OxThera's Unattributed VC - II Round

OxThera raised a round of funding on April 16, 2014.

OxThera is a biopharmaceutical company with products in late stage clinical development focusing on Primary and Secondary Hyperoxaluria. OxThera's intellectual property includes worldwide patents for …

Articles about OxThera's Unattributed VC - II Round: